We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$318B
AUM Growth
+$7.42B
Cap. Flow
+$12.8B
Cap. Flow %
4.02%
Top 10 Hldgs %
13.83%
Holding
10,865
New
1,329
Increased
3,996
Reduced
3,901
Closed
1,130

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$541M
2
MSFT icon
Microsoft
MSFT
+$517M
3
META icon
Meta Platforms (Facebook)
META
+$493M
4
WTW icon
Willis Towers Watson
WTW
+$405M
5
AMZN icon
Amazon
AMZN
+$372M

Sector Composition

Rank Sector Weight
1 Technology 12.18%
2 Financials 7.26%
3 Consumer Discretionary 6.08%
4 Healthcare 6.04%
5 Communication Services 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GROMW
8301
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$7K ﹤0.01%
204
-48
-19% -$1.33K
SCPX
8302
DELISTED
Scorpius Holdings, Inc.
SCPX
0
GGE
8303
DELISTED
Green Giant Inc. Common Stock
GGE
$7K ﹤0.01%
+4,735
New +$8.82K
CYT
8304
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$7K ﹤0.01%
419
-31
-7% -$579
MBAC
8305
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
$7K ﹤0.01%
+659
New +$6.45K
KBNT
8306
DELISTED
Kubient, Inc. Common Stock
KBNT
$7K ﹤0.01%
+2,183
New +$8.78K
SQLLW
8307
DELISTED
SeqLL Inc. Warrant
SQLLW
$7K ﹤0.01%
+6,952
New +$8.11K
HLGN
8308
DELISTED
Heliogen, Inc.
HLGN
$7K ﹤0.01%
20
+14
+233% +$4.85K
EMAN
8309
DELISTED
eMagin Corporation
EMAN
$7K ﹤0.01%
3,187
-2,016
-39% -$5.35K
CCV.WS
8310
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$7K ﹤0.01%
+5,095
New +$7.39K
RADI
8311
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$7K ﹤0.01%
453
-2,745
-86% -$44.1K
APGNW
8312
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$7K ﹤0.01%
+9,955
New +$9.57K
GMVD
8313
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$7K ﹤0.01%
+93
New +$9.81K
ACGN
8314
DELISTED
Aceragen Inc
ACGN
$7K ﹤0.01%
401
+319
+389% +$5.75K
GRNAW
8315
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$7K ﹤0.01%
7,235
-4,006
-36% -$4.2K
NYMX
8316
DELISTED
Nymox Pharmaceutical Corp
NYMX
$7K ﹤0.01%
3,333
-1,889
-36% -$3.35K
AHPI
8317
DELISTED
Allied Healthcare Products
AHPI
$7K ﹤0.01%
1,006
-4,220
-81% -$32.8K
VIVE
8318
DELISTED
VIVEVE MED INC
VIVE
$7K ﹤0.01%
2,969
-6,526
-69% -$16.4K
HCAR
8319
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$7K ﹤0.01%
731
-2,091
-74% -$20.2K
HCII
8320
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$7K ﹤0.01%
712
AGCB
8321
DELISTED
Altimeter Growth Corp 2
AGCB
$7K ﹤0.01%
716
-2,895
-80% -$28.8K
GTPBU
8322
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$7K ﹤0.01%
705
-682
-49% -$6.84K
SHAC
8323
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
$7K ﹤0.01%
700
-269
-28% -$2.6K
FSSIU
8324
DELISTED
Fortistar Sustainable Solutions Corp. Unit
FSSIU
$7K ﹤0.01%
666
-1,118
-63% -$11.3K
CND.WS
8325
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$7K ﹤0.01%
3,946
+3,292
+503% +$6.12K

Similar funds

UBS Group's Q3 2021 Portfolio in Review

As of Q3 2021, UBS Group held 10,865 positions worth $318B, up 2.4% from $310B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $12.8B of net new capital in Q3 2021, opening 1,329 new positions and adding to 3,996 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $626M trimmed.

  • UBS Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.
  • UBS Group added most to Apple in Q3 2021, an estimated $541M increase.
  • UBS Group's biggest Q3 2021 reduction was Invesco QQQ Trust, cutting an estimated $626M.
  • UBS Group fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $282M.
  • UBS Group's ten largest holdings make up 14% of its $318B portfolio in Q3 2021.
  • UBS Group opened 1,329 new positions and closed 1,130 in Q3 2021.
  • UBS Group's portfolio value rose 2.4% quarter-over-quarter to $318B.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.